MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with F

Frovatriptan

Frovatriptan 2.5mg tablets

Use with caution

Stability notes for Frovatriptan 2.5mg tablets

Protect from moisture.

Provenance

This compatibility recommendation is derived from Migard 2.5mg tablets (A. Menarini Farmaceutica Internazionale SRL).

Suppliers (11) of Frovatriptan 2.5mg tablets
Frovatriptan 2.5mg tablets (A A H Pharmaceuticals Ltd)
Frovatriptan 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Frovatriptan 2.5mg tablets (Healthcare Pharma Ltd)
Frovatriptan 2.5mg tablets (Medihealth (Northern) Ltd)
Frovatriptan 2.5mg tablets (Necessity Supplies Ltd)
Frovatriptan 2.5mg tablets (Teva UK Ltd)
Frovatriptan 2.5mg tablets (Viatris UK Healthcare Ltd)
Frovatriptan 2.5mg tablets (Zentiva Pharma UK Ltd)
Migard 2.5mg tablets (A. Menarini Farmaceutica Internazionale SRL)
Mylatrip 2.5mg tablets (Necessity Supplies Ltd)
Mylatrip 2.5mg tablets (Viatris UK Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.